Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Heterogeneity and clinical relevance of group 2 innate lymphoid cells subsets in nasal polyps.

The Journal of allergy and clinical immunology·2026
Same author

The Association Between Sinus Surgery and the Development of Asthma and Non-Cystic Fibrosis Bronchiectasis in Patients With Chronic Rhinosinusitis.

International forum of allergy & rhinology·2025
Same author

Effects of type 3 and neutrophilic inflammation on type 2 chronic rhinosinusitis with nasal polyps.

The Journal of allergy and clinical immunology·2025
Same author

Tezepelumab inhibits highly functional truncated thymic stromal lymphopoietin in chronic rhinosinusitis.

The Journal of allergy and clinical immunology·2025
Same author

Analysis of human neutrophils from nasal polyps by single-cell RNA sequencing reveals roles of neutrophils in chronic rhinosinusitis.

The Journal of allergy and clinical immunology·2024
Same author

Associations Between Chronic Rhinosinusitis and the Development of Non-Cystic Fibrosis Bronchiectasis.

The journal of allergy and clinical immunology. In practice·2024
Same journal

Key factors in the diagnosis of sesame allergy in children.

Allergy and asthma proceedings·2026
Same journal

Immunoglobulin E-mediated pumpkin seed allergy in children: Case series and narrative review with a structured literature search.

Allergy and asthma proceedings·2026
Same journal

Predictors of delayed treatment-free remission with omalizumab in chronic spontaneous urticaria.

Allergy and asthma proceedings·2026
Same journal

The digital front door: A national analysis of U.S. allergy and immunology fellowship program web sites.

Allergy and asthma proceedings·2026
Same journal

The impact of dietary patterns on the risk of asthma in children.

Allergy and asthma proceedings·2026
Same journal

The alpha-gal syndrome: Understanding the role of tick bites, and the delays in severe anaphylaxis.

Allergy and asthma proceedings·2026
See all related articles

Related Experiment Video

Updated: May 20, 2026

Collection and Extraction of Occupational Air Samples for Analysis of Fungal DNA
12:02

Collection and Extraction of Occupational Air Samples for Analysis of Fungal DNA

Published on: May 2, 2018

Chapter 17: Occupational immunologic lung disease.

Bradley R Sabin, Leslie C Grammer

    Allergy and Asthma Proceedings
    |July 17, 2012
    PubMed
    Summary
    This summary is machine-generated.

    Occupational immunologic lung diseases, including occupational asthma and hypersensitivity pneumonitis, stem from workplace airborne agents. Understanding these conditions is crucial for preventing respiratory illnesses in high-risk professions.

    More Related Videos

    Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury
    14:48

    Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury

    Published on: March 21, 2021

    Assessment of the Cytotoxic and Immunomodulatory Effects of Substances in Human Precision-cut Lung Slices
    12:04

    Assessment of the Cytotoxic and Immunomodulatory Effects of Substances in Human Precision-cut Lung Slices

    Published on: May 9, 2018

    Related Experiment Videos

    Last Updated: May 20, 2026

    Collection and Extraction of Occupational Air Samples for Analysis of Fungal DNA
    12:02

    Collection and Extraction of Occupational Air Samples for Analysis of Fungal DNA

    Published on: May 2, 2018

    Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury
    14:48

    Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury

    Published on: March 21, 2021

    Assessment of the Cytotoxic and Immunomodulatory Effects of Substances in Human Precision-cut Lung Slices
    12:04

    Assessment of the Cytotoxic and Immunomodulatory Effects of Substances in Human Precision-cut Lung Slices

    Published on: May 9, 2018

    Area of Science:

    • Pulmonary Medicine
    • Occupational Health
    • Immunology

    Background:

    • Occupational immunologic lung disease involves lung responses to inhaled workplace agents, encompassing occupational asthma (OA) and hypersensitivity pneumonitis (HP).
    • Irritant-induced OA and reactive airways dysfunction syndrome are distinct non-immunologic conditions resulting from irritant exposure.
    • High-risk occupations include farming, printing, woodworking, painting, and healthcare.

    Purpose of the Study:

    • To differentiate between immunologically mediated and non-immunologic occupational lung diseases.
    • To identify triggers and risk factors for occupational asthma and hypersensitivity pneumonitis.
    • To describe the immunological characteristics of hypersensitivity pneumonitis.

    Main Methods:

    • Review of existing literature on occupational immunologic lung diseases.
    • Classification of occupational asthma triggers into high molecular weight (HMW) proteins and low molecular weight (LMW) haptens.
    • Description of hypersensitivity pneumonitis (HP) forms and associated lymphocyte profiles.

    Main Results:

    • Occupational asthma is triggered by HMW allergens (microorganisms, plants, animals) or LMW sensitizers (isocyanates, anhydrides).
    • Hypersensitivity pneumonitis presents acutely, subacutely, or chronically, with early stages showing CD4(+) and CD8(+) lymphocyte alveolitis.
    • A bronchoalveolar lavage CD4/CD8 ratio of <1 is characteristic of HP.

    Conclusions:

    • Occupational lung diseases require careful diagnosis based on exposure history and immunological markers.
    • Awareness of specific triggers and at-risk professions is key for prevention and management.
    • Further research into HMW protein regulation and LMW hapten mechanisms is warranted.